Semaglutide Dosage Guide: Complete Guide 2026

The semaglutide dosage guide for weight loss follows a structured escalation from 0.25 mg weekly to a target maintenance dose of 2.4 mg weekly, spread across approximately 16-20 weeks. This gradual titration minimizes gastrointestinal side effects while allowing your body to adjust to the medication. Your prescribing physician may customize this schedule based on your tolerance and response.

Understanding the Semaglutide Dose Escalation Schedule

Semaglutide (marketed as Wegovy for weight management and Ozempic for type 2 diabetes) is administered as a once-weekly subcutaneous injection. The dose escalation schedule was carefully designed during clinical trials to balance efficacy with tolerability.

The reason for gradual escalation is straightforward. Semaglutide works by mimicking a hormone called GLP-1, which affects appetite centers in the brain and slows gastric emptying. Introducing the medication at full strength would overwhelm these systems, causing severe nausea, vomiting, and diarrhea in most patients. By starting low and increasing slowly, your GLP-1 receptors adapt incrementally. semaglutide how it works

Standard Dose Escalation Schedule for Weight Loss

The FDA-approved escalation schedule for Wegovy (semaglutide 2.4 mg) is as follows:

Standard Semaglutide Dose Escalation for Weight Loss (Wegovy)

Phase	Weeks	Weekly Dose	Purpose
Month 1	Weeks 1-4	0.25 mg	Initial tolerance building
Month 2	Weeks 5-8	0.5 mg	Early dose adjustment
Month 3	Weeks 9-12	1.0 mg	Therapeutic range begins
Month 4	Weeks 13-16	1.7 mg	Near-maintenance dose
Month 5+	Week 17 onward	2.4 mg	Full maintenance dose

Each dose level lasts a minimum of four weeks. This four-week interval gives your body time to adjust before the next increase. In clinical practice, many physicians (including our team at Form Blends) extend certain dose levels beyond four weeks if a patient is experiencing significant side effects.

What Each Dose Level Does

0.25 mg: The Adjustment Phase

At 0.25 mg, you are not yet at a therapeutic dose for weight loss. Think of this as your body's introduction to semaglutide. Most patients notice a mild reduction in appetite and perhaps some light nausea, but significant weight loss is not expected at this level.

What you might experience:

• Mild appetite suppression
• Slight nausea, usually in the first 2-3 days after injection
• Possibly 1-2 pounds of weight loss, though this varies widely

What to focus on: Establishing your injection routine, noting how you feel after injections, and beginning to implement the dietary adjustments that will support your treatment.

0.5 mg: Building Tolerance

At 0.5 mg, appetite suppression becomes more noticeable. Some patients begin to see meaningful weight loss at this dose, though the primary goal is still building tolerance. Nausea may return or intensify for the first week or two after this increase.

Clinical data suggests that the 0.5 mg dose produces roughly 3-5% total body weight loss when used alone for an extended period. However, in the standard protocol, patients spend only four weeks at this dose before advancing.

1.0 mg: Entering the Therapeutic Range

This is where semaglutide starts to show its weight loss potential. At 1.0 mg, the medication's effects on appetite, satiety, and food cravings become pronounced. Many patients describe a noticeable shift in their relationship with food at this dose.

The 1.0 mg dose is also the maintenance dose used for type 2 diabetes (as Ozempic), where it has been shown to produce approximately 6-7% body weight loss. For weight management patients, this dose is a stepping stone to the higher maintenance doses.

This is also the dose level where some patients experience the most challenging side effects. The jump from 0.5 mg to 1.0 mg (a 100% increase) is the largest proportional increase in the escalation schedule. Our physicians pay close attention to patient feedback at this transition.

1.7 mg: Approaching Maintenance

At 1.7 mg, patients are typically experiencing strong appetite suppression and steady weight loss. The jump from 1.0 mg to 1.7 mg is a 70% increase, which can trigger another round of GI adjustment.

Some patients find that 1.7 mg is their optimal maintenance dose. If you are losing weight steadily and tolerating the medication well at this level, your physician may discuss whether advancing to 2.4 mg is necessary. semaglutide weight loss timeline

2.4 mg: Full Maintenance Dose

The 2.4 mg dose is the FDA-approved maintenance dose for weight management. This is the dose used in the pivotal STEP clinical trials, where participants lost an average of 14.9% of their body weight over 68 weeks.

At this dose, the medication's three primary mechanisms are operating at full capacity:

• Central appetite suppression through hypothalamic signaling
• Delayed gastric emptying, creating prolonged feelings of fullness
• Reduced food reward signaling, diminishing cravings

Not every patient will reach or need the 2.4 mg dose. In our practice, approximately 15-20% of patients achieve their weight loss goals at lower doses (typically 1.0 mg or 1.7 mg). This is a perfectly valid outcome and one of the reasons physician supervision is so valuable.

Semaglutide for Diabetes vs. Weight Loss: Dosage Differences

It is important to understand that semaglutide is available under two different brand names with different dosing protocols:

Semaglutide Dosing: Diabetes (Ozempic) vs. Weight Loss (Wegovy)

Feature	Ozempic (Diabetes)	Wegovy (Weight Loss)
FDA-approved indication	Type 2 diabetes	Chronic weight management
Starting dose	0.25 mg weekly	0.25 mg weekly
Maintenance dose	0.5 mg, 1.0 mg, or 2.0 mg	2.4 mg
Escalation period	8 weeks minimum	16 weeks minimum
Available pen strengths	0.25/0.5 mg, 1.0 mg, 2.0 mg	0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg

The key difference is the maximum dose. Wegovy goes up to 2.4 mg for weight management, while Ozempic maxes out at 2.0 mg for diabetes. The formulations are the same molecule; the difference is in the approved dosing and indication.

Compounded Semaglutide Dosing

Compounded semaglutide, which is available through licensed compounding pharmacies, may follow a similar escalation schedule but with more flexibility in dose increments. At Form Blends, our physicians prescribe individualized compounded formulations that allow for precise dose adjustments.

Advantages of compounded semaglutide dosing include:

• Ability to make smaller dose increments (for example, moving from 0.5 mg to 0.75 mg before jumping to 1.0 mg)
• Customized concentrations that reduce the injection volume
• Flexibility to hold at intermediate doses that aren't available in the branded products

This flexibility is particularly valuable for patients who are sensitive to dose changes and need a more gradual escalation than the standard protocol allows.

How to Administer Your Semaglutide Injection

Semaglutide is injected subcutaneously (just under the skin) once per week. Here is a step-by-step guide:

Choosing an Injection Site

You can inject semaglutide in three areas:

• Abdomen: At least 2 inches from your navel. This is the most popular site and offers the most consistent absorption.
• Upper thigh: The front of the thigh, midway between the knee and hip.
• Upper arm: The back of the upper arm (you may need assistance for this site).

Rotate your injection site each week. You can use the same general area (e.g., the abdomen) but inject in a slightly different spot each time to prevent skin irritation or lipodystrophy.

Injection Technique

1. Wash your hands thoroughly with soap and water.
2. Clean the injection site with an alcohol swab and let it dry.
3. Pinch a fold of skin at your chosen injection site.
4. Insert the needle at a 90-degree angle (straight in).
5. Press the injection button and hold for at least 6 seconds to ensure the full dose is delivered.
6. Remove the needle and release the skin fold.
7. If there is a small drop of blood, apply gentle pressure with a clean cotton ball. Do not rub the area.

Timing Your Injection

You can inject semaglutide on any day of the week, with or without food. However, consistency helps. Choose a day that works for your schedule and stick with it. If you need to change your injection day, you can do so as long as there are at least 2 days (48 hours) between doses.

Many of our patients prefer to inject on Friday evenings. This allows any initial nausea (which is most common in the first 24-48 hours after injection) to occur over the weekend rather than during the work week.

What to Do About Missed Doses

Life happens, and you may occasionally miss a dose. Here's the protocol:

If Your Missed Dose Was Less Than 5 Days Ago

Take the missed dose as soon as you remember. Then resume your regular weekly schedule from the date of that injection.

If Your Missed Dose Was 5 or More Days Ago

Skip the missed dose entirely. Take your next dose on your regularly scheduled day. Do not double up on doses to make up for a missed one.

If You've Missed Multiple Consecutive Doses

Contact your physician. If you've missed two or more consecutive doses, your body may have partially lost its adaptation to semaglutide. Your doctor may recommend stepping back to a lower dose and re-escalating to avoid a resurgence of side effects.

Missed Dose Decision Guide

Scenario	Action	Resume Schedule
Missed by 1-4 days	Take the missed dose now	Resume from new injection date
Missed by 5+ days	Skip the missed dose	Take next dose on regular day
Missed 2+ consecutive weeks	Contact your physician	May need to re-escalate from a lower dose

When Your Physician Might Adjust Your Dose

The standard escalation schedule is a starting framework, not an inflexible prescription. Our physicians at Form Blends routinely make adjustments based on individual patient responses. Common scenarios include:

Slowing the Escalation

If you are experiencing moderate to severe GI side effects at a given dose, your physician may extend the time at that dose level from four weeks to six or eight weeks. This gives your body additional time to adjust before the next increase. Research shows that slower escalation does not reduce the ultimate effectiveness of the medication.

Adding an Intermediate Dose

The jump from 0.5 mg to 1.0 mg is particularly challenging for some patients. With compounded semaglutide, your physician can add an intermediate step (such as 0.75 mg) to make this transition smoother.

Reducing the Maintenance Dose

Some patients achieve excellent weight loss results at 1.0 mg or 1.7 mg and experience intolerable side effects at higher doses. In these cases, maintaining at a lower dose is a reasonable clinical decision, especially if the patient is meeting their weight loss goals.

Temporary Dose Reduction

During periods of illness, surgery, or other medical events, your physician may temporarily reduce your dose. Semaglutide should generally not be stopped abruptly, as this can lead to rebound appetite increases.

Dose and Weight Loss: What the Data Shows

The relationship between semaglutide dose and weight loss is well-established in clinical trials:

Weight Loss by Semaglutide Dose (Clinical Trial Data)

Weekly Dose	Average Weight Loss at 68 Weeks	Percentage of Patients Losing 10%+	Trial
0.5 mg	~3.5-5%	~15-20%	SUSTAIN trials
1.0 mg	~6-7%	~25-35%	SUSTAIN trials
2.4 mg	~14.9%	~69%	STEP 1

The data clearly shows that higher doses produce greater weight loss on average. However, individual variation is substantial. Some patients lose 20% or more of their body weight at 2.4 mg, while others may lose closer to 10%. Factors influencing individual response include genetics, baseline metabolic health, diet quality, physical activity level, and medication adherence. semaglutide before and after results

Oral Semaglutide: A Different Dosing Protocol

Semaglutide is also available in an oral tablet form (marketed as Rybelsus for type 2 diabetes). Oral semaglutide follows a different dosing schedule due to the challenges of absorbing a peptide medication through the GI tract.

The oral formulation uses a special absorption enhancer called SNAC (sodium N-[8-(2-hydroxybenzoyl)amino] caprylate) that protects the semaglutide molecule from stomach acid and facilitates its absorption through the stomach lining. Because oral bioavailability is much lower than injectable, the doses are measured in milligrams rather than the microgram-equivalent doses of the injection.

Oral Semaglutide Dosing Schedule (Rybelsus)

Phase	Duration	Daily Dose	Purpose
Initiation	30 days	3 mg	GI tolerance building
Escalation	30 days	7 mg	Approaching therapeutic range
Maintenance	Ongoing	14 mg	Full therapeutic dose

Oral semaglutide must be taken on an empty stomach with no more than 4 ounces of plain water, and you must wait at least 30 minutes before eating, drinking, or taking other medications. These requirements exist because food and additional fluids dramatically reduce absorption. Patients who don't follow these instructions may get little to no benefit from the medication.

Currently, oral semaglutide is FDA-approved only for type 2 diabetes, not for weight management. However, clinical trials of higher oral doses (25 mg and 50 mg) for weight loss are underway and showing promising results.

Special Population Dosing Considerations

Certain patient populations require additional attention when it comes to semaglutide dosing:

Older Adults (65+)

No dose adjustment is required based on age alone. However, older adults may be more susceptible to dehydration from GI side effects, and they may have reduced kidney function that warrants closer monitoring. Our physicians often recommend a slower escalation schedule for patients over 65.

Patients with Kidney Impairment

No dose adjustment is needed for mild, moderate, or severe kidney impairment. However, patients with kidney disease should be monitored more carefully for dehydration, which can worsen kidney function. Semaglutide has not been studied in patients on dialysis.

Patients with Liver Impairment

No dose adjustment is required for patients with mild, moderate, or severe hepatic impairment based on pharmacokinetic studies. Interestingly, semaglutide may actually benefit patients with non-alcoholic fatty liver disease (NAFLD), as clinical trials have shown significant reductions in liver fat content.

Patients Transitioning from Other GLP-1 Medications

If you're switching from another GLP-1 receptor agonist (such as liraglutide or dulaglutide), your physician may modify the escalation schedule. In some cases, patients can start at a higher dose than 0.25 mg because their body has already adapted to GLP-1 receptor activation. This decision should always be made by your prescribing physician based on your specific situation.

Storage and Handling

Proper storage of semaglutide is essential for maintaining its effectiveness:

• Before first use: Store in the refrigerator at 36-46 degrees F (2-8 degrees C). Do not freeze.
• After first use: The pen can be stored at room temperature (up to 86 degrees F / 30 degrees C) or in the refrigerator for up to 28 days.
• Protect from light: Keep the pen cap on when not in use.
• Never freeze: Frozen semaglutide is damaged and should be discarded.
• Travel considerations: Use an insulated cooling pouch for travel. Semaglutide can be at room temperature for up to 28 days, making short trips manageable without refrigeration.

Drug Interactions and Dose Considerations

Because semaglutide slows gastric emptying, it can affect the absorption of other oral medications. Important interactions to be aware of:

• Oral diabetes medications: Insulin and sulfonylureas may need dose reductions to prevent hypoglycemia when combined with semaglutide.
• Blood pressure medications: As weight decreases, blood pressure often improves, potentially requiring dose adjustments to antihypertensives.
• Oral contraceptives: The delayed gastric emptying may theoretically reduce absorption. Discuss with your physician if you rely on oral birth control.
• Warfarin: INR levels should be monitored more frequently when starting or adjusting semaglutide.
• Thyroid medications (levothyroxine): Absorption may be affected. Your physician may recommend timing adjustments.

At Form Blends, we review your complete medication list during your initial consultation and at every follow-up to identify and manage potential interactions.

Frequently Asked Questions About Semaglutide Dosing

Can I start semaglutide at a higher dose to lose weight faster?

No. Starting at a higher dose significantly increases the risk of severe nausea, vomiting, and diarrhea, and does not produce faster long-term weight loss. The escalation schedule exists because clinical trials demonstrated that skipping dose levels leads to higher discontinuation rates. The patients who lose the most weight long-term are those who tolerate the medication well enough to keep taking it.

What if I feel fine at 0.25 mg and want to move up sooner?

We understand the eagerness, but we strongly recommend completing at least four weeks at each dose level. Feeling fine at 0.25 mg does not necessarily mean you'll tolerate 0.5 mg or 1.0 mg without adjustment time. The escalation schedule protects you from side effects at higher doses, not just the current one.

Is it better to inject semaglutide in the morning or at night?

There is no clinical evidence that injection timing affects efficacy. Semaglutide has a half-life of approximately one week, so the time of day you inject has minimal impact on blood levels. Choose a time that's convenient and easy to remember. Some patients prefer evening injections so they can sleep through any initial nausea.

Can I split my weekly dose into smaller daily injections?

No. Semaglutide is specifically formulated for once-weekly injection. Its long half-life (approximately 7 days) means it maintains therapeutic blood levels throughout the week from a single dose. Splitting the dose would complicate administration without providing any benefit.

What happens if I accidentally inject too much semaglutide?

Contact your physician immediately. An overdose of semaglutide would likely cause severe nausea, vomiting, and potentially dangerous drops in blood sugar (especially if you also take diabetes medications). While semaglutide overdose is rarely life-threatening, medical guidance is important. semaglutide side effects

How long will I need to stay on semaglutide?

Semaglutide is approved for long-term, ongoing use. Clinical trials have shown that patients who discontinue semaglutide regain approximately two-thirds of the weight they lost within one year of stopping. Your physician will discuss long-term treatment planning based on your individual situation, goals, and health profile.

Does the dose need to change as I lose weight?

Not typically. Unlike some medications that are dosed by body weight, semaglutide dosing is not adjusted based on your current weight. The maintenance dose remains the same throughout treatment. However, as you lose weight, your physician may need to adjust other medications you take (such as blood pressure or diabetes medications).

Can I take semaglutide with other weight loss medications?

Combining semaglutide with other GLP-1 receptor agonists is contraindicated. Combinations with other weight loss medications (such as phentermine or bupropion/naltrexone) are sometimes used off-label, but should only be considered under close physician supervision. Discuss any combination therapy with your Form Blends physician.

Ready to see if this is right for you? Our board-certified physicians can evaluate your health profile.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Semaglutide is a prescription medication that should only be used under the supervision of a licensed healthcare provider. Dosing decisions should always be made in consultation with your prescribing physician. Individual results may vary. Form Blends provides physician-supervised telehealth consultations; your prescribing physician will determine the appropriate dosing schedule for your individual health needs.